Implications of Biological and Procedural Factors of 18-f FDG Uptake by Normal Organs and Neoplastic Lesions
NCT ID: NCT06626932
Last Updated: 2024-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
259 participants
OBSERVATIONAL
2024-10-31
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response
NCT00180193
Tracer Targeting FAP PET Imaging in Patients
NCT05691894
Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection
NCT06206642
The Role of 18F-FDG-PET/CT Scan in Lung Cancer Patients
NCT04395651
Ultralow Dose PET Imaging of 18F-FDG Uptake
NCT06956391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
18 FDG (Fludeoxyglucose 18F)
18-f FDG
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Year
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
mahenoor alaa eldeen naem
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
mahenoor alaa eldeen naem
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-FDG PET/CT scan
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.